Description
Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified
Affinity’s Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified is the highest level of our Prothrombin Fragment – 1 antibody family. During the Antigen Affinity Purification process the IgG has had any non-specific immunoglobulin fraction eliminated which enriches the specificity of the remaining immunoglobulin towards the target antigen. The result is a very high-purity product with a substantially higher titre than whole or purified IgG. Our Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v) and is intended for applications such as immunoblotting, immunostaining of cells and several types of immunoassays where the higher signal-to-noise ratio achieved with this enriched product is required.
Product Code: SAFII-F1AP
Retail Product Size: 0.5mg vial
Host Animal: Sheep Anti-Human Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified
Species Cross Reactivity: View Chart
Product Datasheet: Prothrombin Fragement 1 Polyclonal Antibody affinity purified anti-human sheep IgG
Description of Prothrombin – Factor II
Prothrombin (factor II, F.II) is a vitamin K-dependent glycoprotein produced in the liver. The concentration of prothrombin in plasma is ~100 μg/ml (~1.4 μM). Prothrombin is a single chain molecule with a molecular weight of 72 kDa. Prothrombin consists of a catalytic domain followed by two kringle structures and an amino-terminal domain containing 10 γ-carboxy-glutamic acid (gla) residues. These gla residues allow prothrombin to bind to membranes that contain acidic phospholipids in a calcium dependent manner. The binding to membranes is required for effective presentation of prothrombin as a substrate for activation by the prothrombinase complex, which consists of activated factor X, activated cofactor V and calcium on phospholipid membrane. Activation by prothrombinase occurs by sequential cleavage after residue Arg320 then after Arg271 to produce the active protease α-thrombin (37 kDa) and the by-product prothrombin fragment 1.2 (35 kDa). The product thrombin further cleaves prothrombin fragment 1.2 after residue Arg155 into individual prothrombin fragments 1 and 2. The activity of α-thrombin in plasma is inhibited primarily by antithrombin and the rate of inhibition is accelerated 1000-fold in the presence of optimal concentrations of heparin. Other physiological inhibitors of thrombin in the absence of heparin include α2macroglobulin and α1antitrypsin1-3.
References and Reviews
1. Mann KG; Prothrombin and Thrombin; in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 184-199, J.B. Lippincott Co., Philadelphia PA, USA, 1994.
2. Mann KG; Prothrombin; Methods in Enzymology 45, pp 123-156, 1976.
3. Downing MW, Bloom JW, Mann KG; Comparison of the Inhibition of Thrombin by Three Plasma Protease Inhibitors; Biochemistry 17, pp 2649-2653, 1978.
Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified
SAFII-F1AP – Sheep anti human Prothrombin Fragment – 1, affinity purified IgG (0.5 mg vial)
Description
Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified
Affinity’s Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified is the highest level of our Prothrombin Fragment – 1 antibody family. During the Antigen Affinity Purification process the IgG has had any non-specific immunoglobulin fraction eliminated which enriches the specificity of the remaining immunoglobulin towards the target antigen. The result is a very high-purity product with a substantially higher titre than whole or purified IgG. Our Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v) and is intended for applications such as immunoblotting, immunostaining of cells and several types of immunoassays where the higher signal-to-noise ratio achieved with this enriched product is required.
Product Code: SAFII-F1AP
Retail Product Size: 0.5mg vial
Host Animal: Sheep Anti-Human Prothrombin Fragment – 1 Polyclonal Antibody – Affinity Purified
Species Cross Reactivity: View Chart
Product Datasheet: Prothrombin Fragement 1 Polyclonal Antibody affinity purified anti-human sheep IgG
Description of Prothrombin – Factor II
Prothrombin (factor II, F.II) is a vitamin K-dependent glycoprotein produced in the liver. The concentration of prothrombin in plasma is ~100 μg/ml (~1.4 μM). Prothrombin is a single chain molecule with a molecular weight of 72 kDa. Prothrombin consists of a catalytic domain followed by two kringle structures and an amino-terminal domain containing 10 γ-carboxy-glutamic acid (gla) residues. These gla residues allow prothrombin to bind to membranes that contain acidic phospholipids in a calcium dependent manner. The binding to membranes is required for effective presentation of prothrombin as a substrate for activation by the prothrombinase complex, which consists of activated factor X, activated cofactor V and calcium on phospholipid membrane. Activation by prothrombinase occurs by sequential cleavage after residue Arg320 then after Arg271 to produce the active protease α-thrombin (37 kDa) and the by-product prothrombin fragment 1.2 (35 kDa). The product thrombin further cleaves prothrombin fragment 1.2 after residue Arg155 into individual prothrombin fragments 1 and 2. The activity of α-thrombin in plasma is inhibited primarily by antithrombin and the rate of inhibition is accelerated 1000-fold in the presence of optimal concentrations of heparin. Other physiological inhibitors of thrombin in the absence of heparin include α2macroglobulin and α1antitrypsin1-3.
References and Reviews
1. Mann KG; Prothrombin and Thrombin; in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 184-199, J.B. Lippincott Co., Philadelphia PA, USA, 1994.
2. Mann KG; Prothrombin; Methods in Enzymology 45, pp 123-156, 1976.
3. Downing MW, Bloom JW, Mann KG; Comparison of the Inhibition of Thrombin by Three Plasma Protease Inhibitors; Biochemistry 17, pp 2649-2653, 1978.